Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$306.88 - $380.0 $28,846 - $35,720
94 Added 13.95%
768 $290,000
Q3 2023

Nov 03, 2023

BUY
$315.92 - $397.36 $3,475 - $4,370
11 Added 1.66%
674 $214,000
Q2 2023

Aug 04, 2023

BUY
$346.15 - $392.09 $11,076 - $12,546
32 Added 5.07%
663 $254,000
Q1 2023

May 01, 2023

BUY
$323.56 - $373.36 $204,166 - $235,590
631 New
631 $235,000
Q2 2022

Aug 02, 2022

SELL
$301.4 - $428.42 $169,386 - $240,772
-562 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$379.46 - $424.54 $3,794 - $4,245
10 Added 1.81%
562 $235,000
Q1 2021

May 10, 2021

BUY
$357.26 - $392.57 $197,207 - $216,698
552 New
552 $212,000
Q1 2020

Apr 24, 2020

SELL
$243.44 - $359.98 $152,880 - $226,067
-628 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$281.18 - $322.05 $176,581 - $202,247
628 New
628 $202,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.